Caseware UK (AP4) 2024.0.164 2024.0.164 2024-12-312024-12-315No description of principal activity2024-01-01false5falsetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false 00601273 2024-01-01 2024-12-31 00601273 2024-12-31 00601273 2022-07-01 2023-12-31 00601273 2023-12-31 00601273 c:Director1 2024-01-01 2024-12-31 00601273 c:RegisteredOffice 2024-01-01 2024-12-31 00601273 d:Buildings d:ShortLeaseholdAssets 2024-01-01 2024-12-31 00601273 d:Buildings d:ShortLeaseholdAssets 2024-12-31 00601273 d:Buildings d:ShortLeaseholdAssets 2023-12-31 00601273 d:PlantMachinery 2024-01-01 2024-12-31 00601273 d:PlantMachinery 2024-12-31 00601273 d:PlantMachinery 2023-12-31 00601273 d:PlantMachinery d:OwnedOrFreeholdAssets 2024-01-01 2024-12-31 00601273 d:MotorVehicles 2024-01-01 2024-12-31 00601273 d:MotorVehicles 2024-12-31 00601273 d:MotorVehicles 2023-12-31 00601273 d:MotorVehicles d:OwnedOrFreeholdAssets 2024-01-01 2024-12-31 00601273 d:FurnitureFittings 2024-01-01 2024-12-31 00601273 d:FurnitureFittings 2024-12-31 00601273 d:FurnitureFittings 2023-12-31 00601273 d:FurnitureFittings d:OwnedOrFreeholdAssets 2024-01-01 2024-12-31 00601273 d:ComputerEquipment 2024-01-01 2024-12-31 00601273 d:ComputerEquipment 2024-12-31 00601273 d:ComputerEquipment 2023-12-31 00601273 d:ComputerEquipment d:OwnedOrFreeholdAssets 2024-01-01 2024-12-31 00601273 d:OwnedOrFreeholdAssets 2024-01-01 2024-12-31 00601273 d:CopyrightsPatentsTrademarksServiceOperatingRights 2024-12-31 00601273 d:CopyrightsPatentsTrademarksServiceOperatingRights 2023-12-31 00601273 d:CurrentFinancialInstruments 2024-12-31 00601273 d:CurrentFinancialInstruments 2023-12-31 00601273 d:CurrentFinancialInstruments d:WithinOneYear 2024-12-31 00601273 d:CurrentFinancialInstruments d:WithinOneYear 2023-12-31 00601273 d:Non-currentFinancialInstruments d:AfterOneYear 2024-12-31 00601273 d:Non-currentFinancialInstruments d:AfterOneYear 2023-12-31 00601273 d:ShareCapital 2024-12-31 00601273 d:ShareCapital 2023-12-31 00601273 d:CapitalRedemptionReserve 2024-12-31 00601273 d:CapitalRedemptionReserve 2023-12-31 00601273 d:OtherMiscellaneousReserve 2024-12-31 00601273 d:OtherMiscellaneousReserve 2023-12-31 00601273 d:RetainedEarningsAccumulatedLosses 2024-12-31 00601273 d:RetainedEarningsAccumulatedLosses 2023-12-31 00601273 c:FRS102 2024-01-01 2024-12-31 00601273 c:AuditExempt-NoAccountantsReport 2024-01-01 2024-12-31 00601273 c:FullAccounts 2024-01-01 2024-12-31 00601273 c:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 00601273 e:PoundSterling 2024-01-01 2024-12-31 iso4217:GBP xbrli:pure
Company registration number: 00601273







UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED
31 DECEMBER 2024


A.C.COSSOR & SON (SURGICAL) LIMITED






































img7abd.png                        

 


A.C.COSSOR & SON (SURGICAL) LIMITED
 


 
COMPANY INFORMATION


Director
R S Singh 




Registered number
00601273



Registered office
Blays Cottage
Blays Lane

Englefield Green

Egham

TW20 0PB




Accountants
Menzies LLP
Chartered Accountants

2nd Floor

Midas House

62 Goldsworth Road

Woking

Surrey

GU21 6LQ





 


A.C.COSSOR & SON (SURGICAL) LIMITED
 



CONTENTS



Page
Statement of financial position
1 - 2
Notes to the financial statements
3 - 8


 


A.C.COSSOR & SON (SURGICAL) LIMITED
REGISTERED NUMBER:00601273



STATEMENT OF FINANCIAL POSITION
AS AT 31 DECEMBER 2024

2024
2023
Note
£
£

Fixed assets
  

Tangible assets
 5 
47,951
21,871

  
47,951
21,871

Current assets
  

Stocks
  
519,365
484,298

Debtors: amounts falling due within one year
 6 
215,619
201,224

Cash at bank and in hand
  
51,000
203,966

  
785,984
889,488

Creditors: amounts falling due within one year
 7 
(789,627)
(637,314)

Net current (liabilities)/assets
  
 
 
(3,643)
 
 
252,174

Total assets less current liabilities
  
44,308
274,045

Creditors: amounts falling due after more than one year
  
(11,668)
(31,668)

  

Net assets
  
32,640
242,377

Page 1

 


A.C.COSSOR & SON (SURGICAL) LIMITED
REGISTERED NUMBER:00601273


    
STATEMENT OF FINANCIAL POSITION (CONTINUED)
AS AT 31 DECEMBER 2024

2024
2023
£
£

Capital and reserves
  

Called up share capital 
  
2,300
2,300

Capital redemption reserve
  
36,922
36,922

Other reserves
  
222
222

Profit and loss account
  
(6,804)
202,933

  
32,640
242,377


The director considers that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of comprehensive income in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 




................................................
R S Singh
Director

Date: 30 June 2025

The notes on pages 3 to 8 form part of these financial statements.

Page 2

 


A.C.COSSOR & SON (SURGICAL) LIMITED
 


 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

1.


General information

A.C.Cossor & Son (Surgical) Limited is a private company limited by shares incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of its registered office and principal place of business is disclosed on the company information page. 

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

Foreign currency translation

Functional and presentation currency

The Company's functional and presentational currency is GBP.

Transactions and balances

Foreign currency transactions are translated into the functional currency using the spot exchange rates at the dates of the transactions.

At each period end foreign currency monetary items are translated using the closing rate. Non-monetary items measured at historical cost are translated using the exchange rate at the date of the transaction and non-monetary items measured at fair value are measured using the exchange rate when fair value was determined.

Foreign exchange gains and losses resulting from the settlement of transactions and from the translation at period-end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognised in profit or loss except when deferred in other comprehensive income as qualifying cash flow hedges.

Foreign exchange gains and losses that relate to borrowings and cash and cash equivalents are presented in the Statement of comprehensive income within 'finance income or costs'. All other foreign exchange gains and losses are presented in profit or loss within 'other operating income'.

Page 3

 


A.C.COSSOR & SON (SURGICAL) LIMITED
 


 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

2.Accounting policies (continued)

 
2.3

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Sale of goods

Revenue from the sale of goods is recognised when all of the following conditions are satisfied:
the Company has transferred the significant risks and rewards of ownership to the buyer;
the Company retains neither continuing managerial involvement to the degree usually associated with ownership nor effective control over the goods sold;
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the transaction; and
the costs incurred or to be incurred in respect of the transaction can be measured reliably.

 
2.4

Research and development

In the research phase of an internal project it is not possible to demonstrate that the project will generate future economic benefits and hence all expenditure on research shall be recognised as an expense when it is incurred. Intangible assets are recognised from the development phase of a project if and only if certain specific criteria are met in order to demonstrate the asset will generate probable future economic benefits and that its cost can be reliably measured. The capitalised development costs are subsequently amortised on a straight-line basis over their useful economic lives, which range from 3 to 6 years.
If it is not possible to distinguish between the research phase and the development phase of an internal project, the expenditure is treated as if it were all incurred in the research phase only.

 
2.5

Finance costs

Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

 
2.6

Borrowing costs

All borrowing costs are recognised in profit or loss in the year in which they are incurred.

 
2.7

Pensions

Defined contribution pension plan

The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Statement of financial position. The assets of the plan are held separately from the Company in independently administered funds.

Page 4

 


A.C.COSSOR & SON (SURGICAL) LIMITED
 


 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

2.Accounting policies (continued)

 
2.8

Taxation

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the Company operates and generates income.

 
2.9

Intangible assets

Intangible assets are initially recognised at cost. After recognition, under the cost model, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

All intangible assets are considered to have a finite useful life. If a reliable estimate of the useful life cannot be made, the useful life shall not exceed ten years.

 
2.10

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, on a reducing balance basis.

Depreciation is provided on the following basis:

Short-term leasehold property
-
Motor vehicles
-
18%
Fixtures and fittings
-
18%
Computer equipment
-
18%

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.11

Financial instruments

The Company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in ordinary shares.

 
2.12

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.

Page 5

 


A.C.COSSOR & SON (SURGICAL) LIMITED
 


 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

3.


Employees

The average monthly number of employees, including directors, during the year was 5 (2023 - 5).


4.


Intangible assets




Trademarks

£



Cost


At 1 January 2024
203



At 31 December 2024

203



Amortisation


At 1 January 2024
203



At 31 December 2024

203



Net book value



At 31 December 2024
-



At 31 December 2023
-



Page 6

 


A.C.COSSOR & SON (SURGICAL) LIMITED
 


 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

5.


Tangible fixed assets





Leasehold property
Plant and machinery
Motor vehicles
Fixtures and fittings
Computer equipment
Total

£
£
£
£
£
£



Cost or valuation


At 1 January 2024
-
6,880
1,995
2,270
31,457
42,602


Additions
25,009
2,325
-
9,525
1,106
37,965


Disposals
-
-
(1,995)
-
-
(1,995)



At 31 December 2024

25,009
9,205
-
11,795
32,563
78,572



Depreciation


At 1 January 2024
-
3,503
1,353
1,326
14,549
20,731


Charge for the year on owned assets
5,002
1,026
116
1,884
3,331
11,359


Disposals
-
-
(1,469)
-
-
(1,469)



At 31 December 2024

5,002
4,529
-
3,210
17,880
30,621



Net book value



At 31 December 2024
20,007
4,676
-
8,585
14,683
47,951



At 31 December 2023
-
3,377
642
944
16,908
21,871


6.


Debtors

2024
2023
£
£


Trade debtors
90,270
109,357

Other debtors
120,961
84,253

Prepayments and accrued income
4,388
7,614

215,619
201,224


Page 7

 


A.C.COSSOR & SON (SURGICAL) LIMITED
 


 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

7.


Creditors: Amounts falling due within one year

2024
2023
£
£

Bank loans
20,000
20,000

Trade creditors
153,230
39,428

Corporation tax
17,092
47,113

Other taxation and social security
4,528
1,753

Other creditors
589,977
525,020

Accruals and deferred income
4,800
4,000

789,627
637,314


 
Page 8